Defiance Daily Target 2X Long LLY ETF (LLYX)

Assets	$36.41M
Expense Ratio	1.32%
PE Ratio	n/a
Shares Out	1.49M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	236,245
Open	23.77
Previous Close	23.53
Day's Range	23.10 - 24.16
52-Week Low	9.60
52-Week High	28.44
Beta	n/a
Holdings	11
Inception Date	Aug 7, 2024

About LLYX

Fund Home Page

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NYSEARCA
• Ticker Symbol: LLYX
• ETF Provider: Defiance

Top 10 Holdings

244.79% of assets

Name	Symbol	Weight
ELI LILLY & CO SWAP Cantor - L	n/a	49.64%
ELI LILLY & CO SWAP CS	n/a	46.92%
ELI LILLY & CO SWAP MAREX	n/a	36.37%
ELI LILLY & CO SWAP MS	n/a	28.39%
ELI LILLY & CO SWAP BMO	n/a	21.29%
OTHER ASSETS AND LIABILITIES	n/a	19.93%
LLY SWAP NOMURA	n/a	19.87%
United States Treasury Bills 0%	B.0 12.18.25	12.00%
US DOLLARS	n/a	9.60%
First American Government Obligations Fund	FGXXX	0.78%

Performance

LLYX had a total return of 9.69% in the past year, including dividends. Since the fund's inception, the average annual return has been -1.06%.